BTN LiveBIG: Groundbreaking blood test to diagnose depression developed at NU
BTN LiveBIG: Groundbreaking blood test to diagnose depression developed at NU
Depression affects more than 350 million people of all ages around the world, and one of the key components to effective treatment of depression is timely and accurate diagnosis. A new blood test developed by a team at Northwestern would be the first of its kind to help predict the outcome of different types of therapy for depression.